Therapeutic Solutions International, Inc. (OTCMKTS:TSOI – Get Rating) saw a sharp decline in short-term interest during the month of May. As of May 15, there was short interest totaling 14,300 shares, down 83.7% from the April 30 total of 87,800 shares. Based on an average trading volume of 10,264,500 shares, the day-to-cover ratio is currently 0.0 day.
The TSOI was down $0.00 during trading hours on Wednesday, hitting $0.02. The stock recorded a trading volume of 2,480,681 shares, compared to an average volume of 5,068,903 shares. The company’s fifty-day simple moving average is $0.02 and its 200-day simple moving average is $0.03. Therapeutic Solutions International has a 1 year minimum of $0.02 and a 1 year maximum of $0.13.
Company Profile Therapeutic Solutions International (Get an assessment)
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immunomodulatory agents against cancers, schizophrenia, suicidal ideation, head trauma and pulmonary pathologies, as well as for everyday health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate and thymoquionone to increase natural killer cell activity and healthy cytokine production.
Get news and reviews for Therapeutic Solutions International Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Therapeutic Solutions International and related companies with MarketBeat.com’s free daily email newsletter.